Conivaptan Hydrochloride Patent Expiration
Conivaptan Hydrochloride is used for treating hyponatremia in patients with excess fluid in the body by blocking arginine vasopressin receptors. It was first introduced by Cumberland Pharmaceuticals Inc
Conivaptan Hydrochloride Patents
Given below is the list of patents protecting Conivaptan Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vaprisol | US5723606 | Condensed benzazepine derivative and pharmaceutical composition thereof |
Dec 15, 2019
(Expired) | Cumberland |
| Vaprisol In 5% Dextrose In Plastic Container | US5723606 | Condensed benzazepine derivative and pharmaceutical composition thereof |
Dec 15, 2019
(Expired) | Cumberland |
Conivaptan Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List